PEP-1-PEA-15 protects against toxin-induced neuronal damage in a mouse model of Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biochimica et Biophysica Acta

• Publication date

  2014-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.bbagen.2014.01.004PMID 24412329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CUL1 promotes trophoblast cell invasion at the maternal–fetal interface

  2013cited by this paper
• PEP-1-ribosomal protein S3 protects dopaminergic neurons in an MPTP-induced Parkinson's disease mouse model.

  2013cited by this paper
• The effect of dopamine on MPTP-induced rotarod disability.

  2013cited by this paper
• Reactive astrocytes associated with plaques in TgCRND8 mouse brain and in human Alzheimer brain express phosphoprotein enriched in astrocytes (PEA‐15)

  2013cited by this paper
• Transduced PEP-1-FK506BP ameliorates corneal injury in Botulinum toxin A-induced dry eye mouse model

  2013cited by this paper
• Peroxisome Proliferator-activated Receptor-γ Activation Enhances Insulin-stimulated Glucose Disposal by Reducing ped/pea-15 Gene Expression in Skeletal Muscle Cells

  2012cited by this paper
• PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma

  2012cited by this paper
• PEP-1-metallothionein-III protein ameliorates the oxidative stress-induced neuronal cell death and brain ischemic insults.

  2012cited by this paper
• Involvement of activation of PI3K/Akt pathway in the protective effects of puerarin against MPP+-induced human neuroblastoma SH-SY5Y cell death.

  2012cited by this paper
• PEP-1-p18 prevents neuronal cell death by inhibiting oxidative stress and Bax expression.

  2012cited by this paper
• PED/PEA-15 induces autophagy and mediates TGF-beta1 effect on muscle cell differentiation

  2012cited by this paper
• Am80 induces neuronal differentiation via increased tropomyosin-related kinase B expression in a human neuroblastoma SH-SY5Y cell line.

  2012cited by this paper
• PEP‐1‐heat shock protein 27 protects from neuronal damage in cells and in a Parkinson’s disease mouse model

  2012cited by this paper
• Protective effects of transduced Tat-DJ-1 protein against oxidative stress and ischemic brain injury

  2012cited by this paper
• Anti-Inflammatory Activities of Inotilone from Phellinus linteus through the Inhibition of MMP-9, NF-κB, and MAPK Activation In Vitro and In Vivo

  2012cited by this paper
• Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation.

  2011cited by this paper
• Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease

  2011cited by this paper
• Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC/Nga mice.

  2011cited by this paper
• Cell-penetrating peptide technology to deliver chaperones and associated factors in diseases and basic research.

  2010cited by this paper
• Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide.

  2010cited by this paper
• PEA-15 Inhibits Tumorigenesis in an MDA-MB-468 Triple-Negative Breast Cancer Xenograft Model through Increased Cytoplasmic Localization of Activated Extracellular Signal-Regulated Kinase

  2010cited by this paper
• Paroxetine Prevents Loss of Nigrostriatal Dopaminergic Neurons by Inhibiting Brain Inflammation and Oxidative Stress in an Experimental Model of Parkinson’s Disease

  2010cited by this paper
• Superoxide is a potential culprit of caspase-3 dependent endothelial cell death induced by lysophosphatidylcholine.

  2010cited by this paper
• Preparation and functional analysis of recombinant protein transduction domain-metallothionein fusion proteins.

  2010cited by this paper
• Transduced Tat-SAG fusion protein protects against oxidative stress and brain ischemic insult.

  2010cited by this paper
• Deletion of PEA-15 in mice is associated with specific impairments of spatial learning abilities

  2009cited by this paper
• Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism.

  2009cited by this paper
• Transduced human PEP-1-catalase fusion protein attenuates ischemic neuronal damage.

  2009cited by this paper
• PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival.

  2008cited by this paper
• Regulation of cell growth by autophagy

  2008cited by this paper
• SAG protects human neuroblastoma SH-SY5Y cells against 1-methyl-4-phenylpyridinium ion (MPP+)-induced cytotoxicity via the downregulation of ROS generation and JNK signaling.

  2007cited by this paper
• PEP-1-SOD fusion protein efficiently protects against paraquat-induced dopaminergic neuron damage in a Parkinson disease mouse model.

  2006cited by this paper
• Oxidative stress and inflammation in Parkinson's disease: is there a causal link?

  2005cited by this paper
• Molecular pathogenesis of Parkinson disease.

  2005cited by this paper
• Neurodegenerative diseases and oxidative stress

  2004cited by this paper
• The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain.

  2004cited by this paper
• In vivo protein transduction: biologically active intact pep-1-superoxide dismutase fusion protein efficiently protects against ischemic insult.

  2004cited by this paper
• The cellular prion protein (PrPC) prevents apoptotic neuronal cell death and mitochondrial dysfunction induced by serum deprivation.

  2004cited by this paper
• Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease.

  2004cited by this paper
• The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in astrocytes.

  2003cited by this paper
• Genetic and environmental factors in the cause of Parkinson's disease

  2003cited by this paper
• PEA-15 Binding to ERK1/2 MAPKs Is Required for Its Modulation of Integrin Activation*

  2003cited by this paper
• Neuroinflammatory processes in Parkinson's disease

  2003cited by this paper
• Modulation of cellular function by TAT mediated transduction of full length proteins.

  2003cited by this paper
• Alpha-synuclein overexpression protects against paraquat-induced neurodegeneration.

  2003cited by this paper
• Molecular Pathways of Neurodegeneration in Parkinson's Disease

  2003cited by this paper
• RSK2 Activity Is Regulated by Its Interaction with PEA-15*

  2003cited by this paper
• α-Synuclein Overexpression Protects against Paraquat-Induced Neurodegeneration

  2003cited by this paper
• Parkinson's Disease Mechanisms and Models

  2003cited by this paper
• Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Death-inducing Signaling Complex and Its Modulation by c-FLIP and PED/PEA-15 in Glioma Cells*

  2002cited by this paper
• Protein transduction technology.

  2002cited by this paper
• BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak.

  2001cited by this paper
• Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse.

  2001cited by this paper
• Proteins linked to a protein transduction domain efficiently transduce pancreatic islets.

  2001cited by this paper
• A peptide carrier for the delivery of biologically active proteins into mammalian cells

  2001cited by this paper
• Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment.

  2001cited by this paper
• PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase.

  2001cited by this paper
• Discriminating mild parkinsonism: Methods for epidemiological research

  2001cited by this paper
• Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism.

  2000cited by this paper
• A comparison of the activity, sequence specificity, and CRM1-dependence of different nuclear export signals.

  2000cited by this paper
• Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias.

  1999cited by this paper
• The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

  1999cited by this paper
• Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked

  1997cited by this paper
• The Major Astrocytic Phosphoprotein PEA-15 Is Encoded by Two mRNAs Conserved on Their Full Length in Mouse and Human*

  1996cited by this paper
• Cellular Expression, Developmental Regulation, and Phylogenic Conservation of PEA‐15, the Astrocytic Major Phosphoprotein and Protein Kinase C Substrate

  1995cited by this paper
• Characterization of PEA-15, a major substrate for protein kinase C in astrocytes.

  1993cited by this paper
• Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice.

  1984cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• COMP Is a Biomarker of Cartilage Destruction, Extracellular Matrix and Vascular Remodeling and Tissue Repair

  2025cites this paper
• Cell death in glioblastoma and the central nervous system

  2024cites this paper
• Anti-tumor activity of propofol: A focus on microRNAs.

  2020cites this paper
• Baicalin Represses C/EBPβ via Its Antioxidative Effect in Parkinson's Disease

  2020cites this paper
• Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment

  2020cites this paper
• PEP-1-GLRX1 protein exhibits anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB pathways in Raw 264.7 cells

  2020cites this paper
• Neuroprotective effects of Tat-ATOX1 protein against MPP+-induced SH-SY5Y cell deaths and in MPTP-induced mouse model of Parkinson's disease.

  2019cites this paper
• Overexpression of phosphoprotein enriched in astrocytes 15 reverses the damage induced by propofol in hippocampal neurons

  2019cites this paper
• PEP-1-PEA15 suppresses inflammatory responses by regulation of MAPK in macrophages and animal models.

  2018cites this paper
• PEP‑1‑glutaredoxin 1 protects against hippocampal neuronal cell damage from oxidative stress via regulation of MAPK and apoptotic signaling pathways.

  2018cites this paper
• Endocannabinoid‐related compounds in gastrointestinal diseases

  2017cites this paper
• Chronic Cerebral Hypoperfusion Induced Synaptic Proteome Changes in the rat Cerebral Cortex

  2017cites this paper
• Fusion with pep-1, a cell-penetrating peptide, enhances the transmembrane ability of human epidermal growth factor

  2016cites this paper
• Parkinson-like phenotype in insulin-resistant PED/PEA-15 transgenic mice

  2016cites this paper
• Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls

  2016cites this paper
• On the Quest of Cellular Functions of PEA-15 and the Therapeutic Opportunities

  2015cites this paper
• The neuroplastic index p-FADD/FADD and phosphoprotein PEA-15, interacting at GABAA receptor, are upregulated in brain cortex during midazolam-induced hypnosis in mice.

  2015cites this paper
• Modifications of natural peptides for nanoparticle and drug design.

  2015cites this paper
• Neuroprotection by Orexin-A via HIF-1α induction in a cellular model of Parkinson's disease.

  2014cites this paper